Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis-expressed protein 12 (TEX12) is a coiled-coil structural protein essential for meiosis, where it acts as a core component of the synaptonemal complex, facilitating homologous chromosome synapsis through fibrous assembly with SYCE2[1][2][4]. TEX12 can also localize to centrosomes, both in meiosis and, aberrantly, in some cancers—where its ectopic expression leads to centrosome abnormalities and is associated with poor clinical outcomes[1][3]. TEX12 exists primarily as a dimer through its central α-helical domain and mediates higher-order assembly of the synaptonemal complex. Aside from its meiotic role, its oncogenic involvement derives from deregulated expression in tumors, making it a cancer-testis antigen and potential biomarker, but no direct drug interactions or specific mechanisms of pharmacological action are established at this time[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis-expressed protein 12 (TEX12).